Get to Know the Endocannabinoid System
The endocannabinoid system (ECS) is a key part of most physiological processes and may have therapeutic potential in almost all diseases affecting humans, but there’s a lot to learn about
Phytecs Expands Scientific Advisory Board with Leading Experts in Mental Health, Inflammation, Metabolism and the Endocannabinoid System
LOS ANGELES–(BUSINESS WIRE)–Phytecs, Inc., a biotechnology company exploring potential therapies that target the body’s endocannabinoid system (ECS) to treat disease, today announced the addition of new members to the company’s
Phytecs Presents New Data on Fluorinated Cannabidiol Derivatives
WASHINGTON–(BUSINESS WIRE)–Phytecs, Inc., a biotechnology company exploring innovative research into and potential treatments targeting the endocannabinoid system (ECS), announced new findings from its study of fluorinated cannabidiol derivatives (F-CBDs) at
Phytecs, Leading U.S. Biotech Focused on the Endocannabinoid System, Partners with Yissum to Discover New ECS-Targeting Compounds, Test Potential of Fluorinated CBD
Professor Raphael Mechoulam, cannabinoid science pioneer, will lead team testing potential of existing proprietary compounds and identifying new compounds targeting specific elements of ECS LOS ANGELES & JERUSALEM–(BUSINESS WIRE)–Phytecs Inc.,
Phytecs Expands Research Slate; Preclinical Data Indicates Its Fluorinated CBD Exhibits Greater Potency Than CBD in Models of Psychiatric Disorders
– Supports Investigation of its HUF-101 Drug Candidate Across a Range of Indications – LOS ANGELES–(BUSINESS WIRE)–Phytecs is expanding its preclinical research program on its novel fluorinated cannabidiol, HUF-101, along
Beyond Cannabis, Many Other Plants Produce Compounds Targeting Body's Endocannabinoid System
LOS ANGELES–(BUSINESS WIRE)–Compelling evidence that many plant species beyond cannabis interact with the body’s endocannabinoid system (ECS) is presented in Dr. Ethan B. Russo’s new cover story for the July
Pioneering Neurologist Ethan Russo, MD, Joins Phytecs: First Biotech Firm to Develop Consumer Healthcare Products Targeting Endocannabinoid System
LOS ANGELES-(BUSINESS WIRE)- Phytecs, a California biotechnology company that researches and develops consumer healthcare products targeting the body’s endocannabinoid system (ECS), today announced that Dr. Ethan Russo. MD, has joined
Leading Endocannabinoid Scientist, Former House Majority Whip Join Phytecs
Dr. Raphael Mechoulam, Former Rep. Tony Coelho Bring Global Scientific and Policy Expertise to California Biotech Company LOS ANGELES–(BUSINESS WIRE)–Phytecs, a biotechnology company that researches and develops new healthcare and